Astec LifeSciences Board Approves FY2026 Results, Sets Dates for 32nd AGM
Astec LifeSciences Limited announced key resolutions following its Board of Directors meeting held on Monday, April 27, 2026. The Board approved the audited financial results and also scheduled the dates for the upcoming 32nd Annual General Meeting (AGM) and the related shareholder proposals.Approval of Financial Results
The Board of Directors approved the Audited Financial Results (Standalone & Consolidated) for the Quarter and Financial Year ended March 31, 2026, in accordance with Indian Accounting Standards (IND AS). The approval covered the financial results, the Cash Flow Statement, and the Statement of Assets and Liabilities as of March 31, 2026.The company noted that the Statutory Auditors issued reports on the results for the Quarter and Financial Year ended March 31, 2026, with an unmodified opinion for both the standalone and consolidated financial results.
Annual General Meeting and Shareholder Proposals
The Board also finalized the dates for the 32nd Annual General Meeting (AGM) of the company's shareholders.The AGM is set to be held on Friday, July 31, 2026, at 4:00 p.m. The corresponding Book Closure Dates for the AGM have been scheduled from Sunday, July 26, 2026, to Thursday, July 30, 2026.
Furthermore, the Board approved a proposal to seek shareholder consent for several important matters through a Postal Ballot. These proposals include:
- The appointment of Mr. Vishal Sharma as an Additional Director, designated as a Non-Executive Director liable to retire by rotation.
- The appointment of Mr. Burjis N. Godrej as an Additional Director, designated as a Non-Executive Director liable to retire by rotation.
- The appointment and remuneration of Mr. Arijit Mukherjee as an Executive Director, while continuing his role as Chief Operating Officer.
- The appointment of Mr. Mathew Eipe as an Independent Director.
- Approval for entering into Material Related Party Transactions during the Financial Year 2026-27.
Consolidated Group Entities
The consolidated annual financial results include the results of multiple entities. The components of the group listed in the financial results are:| Sr. No | Name of Component | Relationship |
|---|---|---|
| 1 | Astec LifeSciences Limited | Holding Company |
| 2 | Behram Chemicals Private Limited | Subsidiary Company |
| 3 | Comercializadora Agricola Agroastrachem Cia Ltda | Subsidiary Company |
***
Disclaimer: This article is based solely on public corporate disclosures and does not constitute financial advice.
ASTEC Stock Price Movement
Today, shares of Astec LifeSciences Limited rallied, closing at ₹749.9, reflecting a solid 3.88% gain for the day. The equity saw robust trading activity, matching a volume of 96,049 shares while moving significantly above its previous close of ₹720.8.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.